Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Juraj Madaric"'
Autor:
Lydia Hanna, Alexander D. Rodway, Puneet Garcha, Luci Maynard, Janane Sivayogi, Oliver Schlager, Juraj Madaric, Vinko Boc, Lucas Busch, Martin B. Whyte, Simon S. Skene, Jenny Harris, Christian Heiss
Publikováno v:
EClinicalMedicine, Vol 75, Iss , Pp 102788- (2024)
Summary: Background: Timely and economic provision of revascularisation procedures is a major healthcare need. We aimed to examine the safety and efficacy of daycase-based lower extremity endovascular revascularisation procedures in patients with per
Externí odkaz:
https://doaj.org/article/e636642c48bf4cada56864763a237778
Autor:
Jan Kyselovic, Adriana Adamičková, Andrea Gažová, Simona Valášková, Nikola Chomaničová, Zdenko Červenák, Juraj Madaric
Publikováno v:
Biomedicines, Vol 12, Iss 4, p 922 (2024)
Background: The present study investigated the outcomes and possible predictive factors of autologous bone marrow cells (BMCs) therapy in patients with ”no-option“ critical limb ischaemia (CLI). It was focused on exploring the clinical background
Externí odkaz:
https://doaj.org/article/8010bebd6f7243b19be4013568b35b0e
Autor:
Gualtiero Palareti MD, Angelo A. Bignamini MD, Michela Cini PhD, Young-Jun Li MD, Tomasz Urbanek MD, Juraj Madaric MD, Kamel Bouslama MD, German Y. Sokurenko MD, Giuseppe M. Andreozzi MD, Jiří Matuška MD, Armando Mansilha MD, Victor Barinov MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
Background International guidelines recommend at least three months anticoagulation in all patients after acute venous thromboembolism (VTE) and suggest those with unprovoked events be considered for indefinite anticoagulation if the risk of recurren
Externí odkaz:
https://doaj.org/article/9dc7d1f96b004974aa66dfd6b56b529e
Autor:
Juraj Madaric, Martina Valachovicova, Ludovit Paulis, Jana Pribojova, Renata Mateova, Katarina Sebekova, Luba Postulkova, Terezia Madaricova, Maria Bucova, Martin Mistrik, Ivan Vulev
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-7 (2017)
Abstract Background Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, acts as an inhibitor of angiogenesis and is associated with an increased risk of cardiovascular mortality. Administration of stem cells may affe
Externí odkaz:
https://doaj.org/article/8f41f8f749b3438aa73cf3bf74517b9b
Autor:
Stefano Lanzi, Jill Belch, Marianne Brodmann, Juraj Madaric, Alessandra Bura-Riviere, Adriana Visonà, Lucia Mazzolai
Publikováno v:
Vasa. 51:267-274
Summary: The optimal first line management of patients with symptomatic chronic lower extremity peripheral artery disease (PAD) includes secondary prevention of cardiovascular risk factors, pharmacological treatment, and supervised exercise therapy (
Autor:
Christian Heiss, Dan-Mircea Olinic, Jill J. F. Belch, Marianne Brodmann, Lucia Mazzolai, Agata Stanek, Juraj Madaric, Andrew Krentz, Oliver Schlager, Michael Lichtenberg, Ulrich Frank
Publikováno v:
Vasa. 51:121-137
Summary: With an increasing global burden of patients with chronic peripheral artery disease (PAD) the safe and effective provision of lower limb revascularisation is a growing medical need. Endovascular procedures for the treatment of PAD have becom
Autor:
Juraj Madaric, Maria Amitrano, Isabelle Quéré, Lucia Mazzolai, Marzia Lugli, Paolo Prandoni, Adriana Visonà
Publikováno v:
Vasa. 50:331-340
Summary: Post-thrombotic syndrome (PTS) is a chronic venous insufficiency manifestation following an episode of deep-vein thrombosis (DVT). It is an important and frequent long-term adverse event of proximal DVT affecting 20–50% of patients. This p
Autor:
Jorge Francisco Gomez-Cerezo, Jean-Baptiste Ricco, Juraj Madaric, Rupert Bauersachs, Marianne Brodmann, Lucia Mazzolai, Christopher E Clark, Victor Aboyans, Henrik Sillesen, Sebastian Debus, Marco De Carlo
Publikováno v:
Bauersachs, R, Brodmann, M, Clark, C, Debus, S, De Carlo, M, Gomez-Cerezo, J F, Madaric, J, Mazzolai, L, Ricco, J B, Sillesen, H & Aboyan, V 2021, ' International public awareness of peripheral artery disease ', Vasa-European Journal of Vascular Medicine, vol. 50, no. 4, pp. 294-300 . https://doi.org/10.1024/0301-1526/a000945
Summary: Background: Peripheral artery disease (PAD) of the lower limbs is a common condition with considerable global burden. Some country-specific studies suggest low levels of public awareness. To our knowledge public awareness of PAD has never be
Autor:
Nicole Jaeger, Marc P. Bonaca, Mark R. Nehler, David Szalay, Henrik Sillesen, Sonia S. Anand, Taylor Brackin, Connie N. Hess, Eva Muehlhofer, Eike Sebastian Debus, William R. Hiatt, David Brasil, Rupert Bauersachs, Warren H. Capell, Manesh R. Patel, Lloyd Haskell, Akos F. Pap, Juraj Madaric, Scott D. Berkowitz
Publikováno v:
Circulation. 142:2219-2230
Background: The VOYAGER PAD trial (Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgical Limb Revascularization for Peripheral Artery Disease) demonstrated superiority of rivaroxaban plus aspirin versus aspirin to reduce m
Autor:
Katarina Grossmannova, Monika Barathova, Petra Belvoncikova, Viliam Lauko, Lucia Csaderova, Jan Tomka, Tomas Dulka, Jaromir Pastorek, Juraj Madaric
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 879, p 879 (2022)
International Journal of Molecular Sciences; Volume 23; Issue 2; Pages: 879
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 23; Issue 2; Pages: 879
International Journal of Molecular Sciences
Abdominal aortic aneurysms (AAA) are a significant cause of premature deaths worldwide. Since there is no specific treatment for reducing AAA progression, it is crucial to understand the pathogenesis leading to aneurysm wall weakening/remodeling and